Genetron GTH Stock
Genetron Price Chart
Genetron GTH Financial and Trading Overview
| Genetron stock price | 4.03 USD |
| Previous Close | 0.91 USD |
| Open | 0.91 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1300 |
| Day's Range | 0.91 - 0.93 USD |
| 52 Week Range | 0.73 - 1.75 USD |
| Volume | 17.88K USD |
| Avg. Volume | 29.1K USD |
| Market Cap | 85.13M USD |
| Beta (5Y Monthly) | 0.523255 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.34 USD |
GTH Valuation Measures
| Enterprise Value | -94717056 USD |
| Trailing P/E | N/A |
| Forward P/E | -5.811875 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.13082889 |
| Price/Book (mrq) | 0.1558927 |
| Enterprise Value/Revenue | -0.146 |
| Enterprise Value/EBITDA | 0.145 |
Trading Information
Genetron Stock Price History
| Beta (5Y Monthly) | 0.523255 |
| 52-Week Change | -33.093% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.75 USD |
| 52 Week Low | 0.73 USD |
| 50-Day Moving Average | 0.92 USD |
| 200-Day Moving Average | 0.98 USD |
GTH Share Statistics
| Avg. Volume (3 month) | 29.1K USD |
| Avg. Daily Volume (10-Days) | 61.13K USD |
| Shares Outstanding | 90.6M |
| Float | 41.09M |
| Short Ratio | 4.31 |
| % Held by Insiders | 6.94% |
| % Held by Institutions | 12.15% |
| Shares Short | 118.03K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -124.23% |
| Operating Margin (ttm) | -107.87% |
| Gross Margin | 43.25% |
| EBITDA Margin | -100.083% |
Management Effectiveness
| Return on Assets (ttm) | -35.19% |
| Return on Equity (ttm) | -92.20% |
Income Statement
| Revenue (ttm) | 650.71M USD |
| Revenue Per Share (ttm) | 7.01 USD |
| Quarterly Revenue Growth (yoy) | 37.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -651244032 USD |
| Net Income Avi to Common (ttm) | -808403008 USD |
| Diluted EPS (ttm) | -1.25 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 338.86M USD |
| Total Cash Per Share (mrq) | 3.7 USD |
| Total Debt (mrq) | 158.57M USD |
| Total Debt/Equity (mrq) | 28.92 USD |
| Current Ratio (mrq) | 1.818 |
| Book Value Per Share (mrq) | 5.965 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -460196992 USD |
| Levered Free Cash Flow (ttm) | -317697248 USD |
Profile of Genetron
| Country | United States |
| State | N/A |
| City | Beijing |
| Address | Building 11 |
| ZIP | 102206 |
| Phone | 86 10 5090 7500 |
| Website | https://www.genetronhealth.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 993 |
Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.
Q&A For Genetron Stock
What is a current GTH stock price?
Genetron GTH stock price today per share is 4.03 USD.
How to purchase Genetron stock?
You can buy GTH shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genetron?
The stock symbol or ticker of Genetron is GTH.
Which industry does the Genetron company belong to?
The Genetron industry is Diagnostics & Research.
How many shares does Genetron have in circulation?
The max supply of Genetron shares is 31.62M.
What is Genetron Price to Earnings Ratio (PE Ratio)?
Genetron PE Ratio is 0.00000000 now.
What was Genetron earnings per share over the trailing 12 months (TTM)?
Genetron EPS is 0 USD over the trailing 12 months.
Which sector does the Genetron company belong to?
The Genetron sector is Healthcare.
Genetron GTH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}